Skip to main content
. Author manuscript; available in PMC: 2019 May 1.
Published in final edited form as: Expert Opin Ther Targets. 2018 Oct 17;22(11):929–939. doi: 10.1080/14728222.2018.1535594

Figure 1.

Figure 1.

miRNA prognostic plots from two let-7 family member that may benefit most from let-7 therapy. (a) Overall survival of hsa-let-7b miRNA expression in Kidney renal clear cell carcinoma. (b) Overall survival of hsa-let-7i miRNA expression in Brain lower grade glioma.